Recently, there is a very positive development in the field of targeted treatment of breast cancer. Treatment pointing at individual patients according to the type of their tumor is becoming clearer.
A series of clinical studies, some of which are still on-going, are solving the problem of treatment indiaction, its dosage, duration and combinations.